FHL2 and renal fibrosis: The likely mechanism is that FHL2 is a potent activator of the Wnt/β-catenin and TGFβ/β-catenin pathways (major drivers of renal fibrosis), and accordingly its absence abrogates the nuclear accumulation and activity of β-catenin [118,122].